PharmaCyte Biotech Inc (PMCB): Cool, rereading that interview actually...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	55
Posts	2608
Boards Moderated	0
Alias Born	02/04/2014

Peacefulwendy

Re: efood125 post# 42369

Wednesday, 10/21/2015 9:46:11 PM

Wednesday, October 21, 2015 9:46:11 PM

Cool, rereading that interview actually cleared up some things for me too in understanding the two phase 1 trials... That interview and GCs explanation of the different causes of pain really made the need for 2 separate trials more clear. Thanks GC... :)

It also makes more sense why we combined the pain and quality of life with the 2b trials...

"The trial design also includes several secondary endpoints. Among the most important are: (i) the onset of pain and the patient’s need for pain medications; (ii) whether the inoperable tumors become operable as a result of the treatment; (iii) the change in tumor size; and (iv) the patient’s overall quality of life during the treatment".

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117889505

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117889114

http://ih.advfn.com/p.php?pid=nmona&article=68966185&symbol=PMCB